Axanum low dose aspirin/esomeprazole magnesium combination product regulatory update

AstraZeneca withdrew an NDA for Axanum aspirin/esomeprazole to reduce the risk of low-dose aspirin-associated gastric and/or duodenal ulcers for commercial reasons. FDA issued a complete response lett...